Breast biopsy devices are used for laboratory testing by removal of small portion of breast tissue. Breast biopsy procedures are used for the detection of cysts and to identify whether it is cancerous or not. Brest biopsy is used for detecting lump or thickening in breast, suspicious area in breast, unusual nipple or areolar changes and others. For the purpose of breast biopsy, components for instance, fine-needle aspiration biopsy, core needle biopsy, stereotactic biopsy and ultrasound-guided core needle biopsy are used. Fine-needle aspiration biopsy is the simplest type of breast biopsy that can be used to evaluate a lump that may be felt during a clinical breast exam. The tissues obtained through the biopsy procedure are sent to lab, where a pathologist analyzes blood and body tissue by examining the sample using a microscope and special procedures. Breast biopsy performed through surgical procedure is known as incisional biopsy. In incisional biopsy, a portion of the breast mass is removed in an operating room. On the back of rising consumer preference towards nominally invasive procedures, the breast biopsy devices market is anticipated to increase.
The global breast biopsy device market is observing vibrant growth on the back of increasing demand of diagnostic procedures for scaling, or crusting of the breast skin. Advancements in healthcare industry in the past few years and growing breast cancer incidences is projected to drive breast biopsy device market besides the wide range of functions of breast biopsy device in detection of abnormal changes in the nipple for instance, cellulite and congealing during the forecast period.
Breast biopsy device market is anticipated to record a CAGR of 5.5% over the forecast period. The Breast biopsy devices market is expected to value at USD 14.3 million at the end of the forecast period. Many multi-national companies are concentrating towards new product advances in breast biopsy devices. Moreover, rising cases of breast cancers reported by European Breast Cancer Coalition, International Association of Cancer Registries and others, is subsequently estimated to drive the breast biopsy market rapidly. On the basis of regional platform, global Breast Biopsy Device market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
Being a developed region with excellent healthcare facilities, North America is panned to observe significant growth in breast biopsy device market due to rising breast biopsy device usage for detecting cellulite and surgical cysts in women. North America is estimated to be followed by Asia Pacific in terms of usage due to expanding breast biopsy device requirements in growing female cancer population across the region. Europe is expected to drive demand and positively impact breast biopsy device market growth over the forecast period owing to increasing geriatric female population suffering from breast cancer across the region.CLICK TO DOWNLOAD FREE SAMPLE
On the back of rising incidences of cancer in the global population, the breast biopsy device market is anticipated to increase over the forecast period. World Health Organization reports breast cancer as one of the leading causes of deaths in cancer patients. According to WHO statistics released on September 2018, 627 000 deaths were caused around the globe due to breast cancer. The cause behind breast cancer can be attributed to various factors such as, increasing alcohol consumption in women, rising female smocking population, with growing adoption of sedentary lifestyle and unhealthy eating among the women population across the globe.
Additionally, the number of incidences of cancer is anticipated to increase on the back of rise in mutational changes in the human body along with increasing exposure of skin to ultra-violet rays. These factors together are expected to propel the breast biopsy market significantly during the forecast period. Moreover, World Health Organization reports suggest that around one third of deaths from cancer are due to behavioral and dietary risks for instance, low fruit and vegetable intake, lack of physical activity and high body mass index. Growing female obese population are highly prone to breast cancer which is estimated to drive the breast biopsy market robustly during the forecast period across the globe.
However, lack of awareness in the female population regarding biopsy procedures and presence of sub-standard healthcare facilities results in 70% of cancer deaths approximately, in low- and middle-income countries, which is expected to hinder the steady growth of the breast biopsy devices market over the forecast period around the under-developed and some developing regions around the world.
Our-in depth analysis of the global Breast Biopsy Device market includes the following segments:
Global Breast Biopsy Device Market is further classified on the basis of region as follows:
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization